Alcon AG (ALC)
70.50
-1.58
(-2.19%)
USD |
NYSE |
Sep 04, 16:00
70.68
+0.18
(+0.26%)
After-Hours: 20:00
Alcon Research and Development Expense (Quarterly) : 663.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 663.00M |
| March 31, 2026 | 245.00M |
| December 31, 2025 | 273.00M |
| September 30, 2025 | 250.00M |
| June 30, 2025 | 245.00M |
| March 31, 2025 | 222.00M |
| December 31, 2024 | 232.00M |
| September 30, 2024 | 225.00M |
| June 30, 2024 | 220.00M |
| March 31, 2024 | 199.00M |
| December 31, 2023 | 208.00M |
| September 30, 2023 | 201.00M |
| June 30, 2023 | 217.00M |
| March 31, 2023 | 202.00M |
| December 31, 2022 | 198.00M |
| September 30, 2022 | 153.00M |
| June 30, 2022 | 174.00M |
| March 31, 2022 | 160.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 174.00M |
| September 30, 2021 | 135.00M |
| June 30, 2021 | 178.00M |
| March 31, 2021 | 166.00M |
| December 31, 2020 | 155.00M |
| September 30, 2020 | 211.00M |
| June 30, 2020 | 155.00M |
| March 31, 2020 | 166.00M |
| December 31, 2019 | 147.00M |
| September 30, 2019 | 172.00M |
| June 30, 2019 | 159.00M |
| March 31, 2019 | 141.00M |
| December 31, 2018 | 166.00M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 145.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.32M |
| Metall Zug AG | -- |
| Ypsomed Holding AG | -- |
| Straumann Holding AG | -- |
| Medacta Group SA | -- |